104 related articles for article (PubMed ID: 19001475)
1. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure.
Abrahamsson P; Dobson J; Granger CB; McMurray JJ; Michelson EL; Pfeffer M; Pocock S; Solomon SD; Yusuf S; Swedberg K;
Eur Heart J; 2009 Feb; 30(3):338-45. PubMed ID: 19001475
[TBL] [Abstract][Full Text] [Related]
2. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.
Demers C; McMurray JJ; Swedberg K; Pfeffer MA; Granger CB; Olofsson B; McKelvie RS; Ostergren J; Michelson EL; Johansson PA; Wang D; Yusuf S;
JAMA; 2005 Oct; 294(14):1794-8. PubMed ID: 16219883
[TBL] [Abstract][Full Text] [Related]
3. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.
Solomon SD; Dobson J; Pocock S; Skali H; McMurray JJ; Granger CB; Yusuf S; Swedberg K; Young JB; Michelson EL; Pfeffer MA;
Circulation; 2007 Sep; 116(13):1482-7. PubMed ID: 17724259
[TBL] [Abstract][Full Text] [Related]
4. Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes.
Mehta SR; Eikelboom JW; Demers C; Maggioni AP; Commerford PJ; Yusuf S
Can J Physiol Pharmacol; 2005 Jan; 83(1):98-103. PubMed ID: 15759056
[TBL] [Abstract][Full Text] [Related]
5. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.
Pocock SJ; McMurray JJ; Dobson J; Yusuf S; Granger CB; Michelson EL; Ostergren J; Pfeffer MA; Solomon SD; Anker SD; Swedberg KB
Eur Heart J; 2008 Nov; 29(21):2641-50. PubMed ID: 18819960
[TBL] [Abstract][Full Text] [Related]
6. Management and outcomes following an acute coronary event in patients with chronic heart failure 1999-2007.
Ranasinghe I; Naoum C; Aliprandi-Costa B; Sindone AP; Steg PG; Elliott J; McGarity B; Lefkovits J; Brieger D;
Eur J Heart Fail; 2012 May; 14(5):464-72. PubMed ID: 22499543
[TBL] [Abstract][Full Text] [Related]
7. Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme.
Cohen-Solal A; McMurray JJ; Swedberg K; Pfeffer MA; Puu M; Solomon SD; Michelson EL; Yusuf S; Granger CB;
Eur Heart J; 2008 Dec; 29(24):3022-8. PubMed ID: 18987098
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
[TBL] [Abstract][Full Text] [Related]
9. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
[TBL] [Abstract][Full Text] [Related]
10. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
Kenchaiah S; Pocock SJ; Wang D; Finn PV; Zornoff LA; Skali H; Pfeffer MA; Yusuf S; Swedberg K; Michelson EL; Granger CB; McMurray JJ; Solomon SD;
Circulation; 2007 Aug; 116(6):627-36. PubMed ID: 17638930
[TBL] [Abstract][Full Text] [Related]
11. GRACE score predicts heart failure admission following acute coronary syndrome.
McAllister DA; Halbesma N; Carruthers K; Denvir M; Fox KA
Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):165-71. PubMed ID: 24986419
[TBL] [Abstract][Full Text] [Related]
12. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction.
Thune JJ; Signorovitch JE; Kober L; McMurray JJ; Swedberg K; Rouleau J; Maggioni A; Velazquez E; Califf R; Pfeffer MA; Solomon SD
Eur J Heart Fail; 2011 Feb; 13(2):148-53. PubMed ID: 21037250
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme.
Badar AA; Perez-Moreno AC; Hawkins NM; Brunton AP; Jhund PS; Wong CM; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Gardner RS; Petrie MC; McMurray JJ
Eur J Heart Fail; 2015 Feb; 17(2):196-204. PubMed ID: 25678097
[TBL] [Abstract][Full Text] [Related]
14. Comparison of long-term mortality across the spectrum of acute coronary syndromes.
Allen LA; O'Donnell CJ; Camargo CA; Giugliano RP; Lloyd-Jones DM
Am Heart J; 2006 May; 151(5):1065-71. PubMed ID: 16644337
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
16. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).
Steg PG; Dabbous OH; Feldman LJ; Cohen-Solal A; Aumont MC; López-Sendón J; Budaj A; Goldberg RJ; Klein W; Anderson FA;
Circulation; 2004 Feb; 109(4):494-9. PubMed ID: 14744970
[TBL] [Abstract][Full Text] [Related]
17. Incidence of heart failure and mortality after acute coronary syndromes.
Kaul P; Ezekowitz JA; Armstrong PW; Leung BK; Savu A; Welsh RC; Quan H; Knudtson ML; McAlister FA
Am Heart J; 2013 Mar; 165(3):379-85.e2. PubMed ID: 23453107
[TBL] [Abstract][Full Text] [Related]
18. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF.
Jánosi A; Ghali JK; Herlitz J; Czuriga I; Klibaner M; Wikstrand J; Hjalmarson A;
Am Heart J; 2003 Oct; 146(4):721-8. PubMed ID: 14564329
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
20. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
